| General Information of Drug (ID:
DR0811) |
| Drug Name |
Human calcitonin
|
| Synonyms |
Calcitonin (human synthetic); Calcitonin (human); Calcitonin human; Calcitonin, human; Calcitonin, human synthetic |
| Indication |
Hyperparathyroidism
[ICD11: 5A51]
|
Phase 4
|
[1]
|
| Structure |
|
 |
|
3D MOL is unavailable
|
2D MOL
|
| Cross-matching ID |
|
|
|
|
|
|
|
|
| Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug |
| DME Name |
DME Info |
Species |
Uniprot ID |
EC Number |
REF |
|
Alanyl aminopeptidase (ANPEP)
|
DME0145
|
Homo sapiens
|
|
|
[2]
|
|
Alpha-N-acetylglucosaminidase (NAG)
|
DME0144
|
Homo sapiens
|
|
|
[2]
|
|
Phosphoglucomutase 1 (PGM1)
|
DME0146
|
Homo sapiens
|
|
|
[2]
|
|
|
|
|
|
|
|
| References |
| 1 |
ClinicalTrials.gov (NCT03935984) Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity.
|
| 2 |
Renal metabolism of calcitonin. Am J Physiol. 1988 Apr;254(4 Pt 2):F593-600.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
